What is the exercise price of the options, and will the issuance of new shares cause dilution or have a material impact on earnings per share?

Exercise price – The announcement does not disclose the specific strike price of the 80 000 options. The terms were set in the 26 August 2022 share‑based option program, which generally fixes the exercise price at the market price on the grant date (the price at which the options were originally granted to Knut Nesse). In the absence of an explicit figure, the strike is presumed to be close to the share price at the time of the 2022 grant, which was well below today’s market level.

Dilution / EPS impact – Issuing 80 000 new shares represents a very small fraction of AKVA Group’s capital base (the company has several million shares outstanding). Numerically, the increase is well under 1 % of the total share count, so the dilution effect on ownership percentages is negligible. Likewise, the incremental share count is too modest to move earnings per share in any material way, even assuming a proportional increase in net income. Consequently, the market should not price in a significant EPS hit, and the exercise is unlikely to affect the stock’s valuation metrics beyond a trivial, short‑term uptick in float.

Trading implication – Because the option exercise is non‑material, it should not trigger any re‑rating of AKVA’s fundamentals. Traders can treat the event as a routine corporate action and focus on the broader technical picture and sector dynamics rather than expecting a price move from dilution concerns. If the current price is trading near the historic strike level, the exercise may simply add a modest amount of liquidity to the market without altering the trend.